183 related articles for article (PubMed ID: 36572814)
21. [Clinical characteristics and therapeutic effect of TP53 variant in patients with acute leukemia].
Mi R; Guo Z; Liu W; Hu J; Fan R; Chen L; Liu J; Wei X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Oct; 38(10):955-960. PubMed ID: 34625931
[TBL] [Abstract][Full Text] [Related]
22. Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.
Nahi H; Lehmann S; Bengtzen S; Jansson M; Möllgård L; Paul C; Merup M
Leuk Lymphoma; 2008 Mar; 49(3):508-16. PubMed ID: 18297528
[TBL] [Abstract][Full Text] [Related]
23. TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype.
Ren Y; Wang J; Zhang H; Mei C; Ye L; Luo Y; Zhou X; Zhu S; Jiang L; Wang L; Jin J; Tong H
Asia Pac J Clin Oncol; 2020 Jun; 16(3):172-179. PubMed ID: 32030889
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of AML-MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC-defining criteria, TP53 allelic state, or TP53 variant allele frequency.
Zhao D; Eladl E; Zarif M; Capo-Chichi JM; Schuh A; Atenafu E; Minden M; Chang H
Cancer Med; 2023 Mar; 12(6):6511-6522. PubMed ID: 36394085
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic dysplasia and aberrant T-cell antigen expression in acute myeloid leukaemia with complex karyotype and
Dannheim KC; Pozdnyakova O; Dal Cin P; Weinberg OK
J Clin Pathol; 2018 Dec; 71(12):1051-1059. PubMed ID: 30171088
[TBL] [Abstract][Full Text] [Related]
26. Cytogenetic and mutational analysis and outcome assessment of a cohort of 284 children with de novo acute myeloid leukemia reveal complex karyotype as an adverse risk factor for inferior survival.
Chen X; Wang X; Dou H; Yang Z; Bi J; Huang Y; Lu L; Yu J; Bao L
Mol Cytogenet; 2021 May; 14(1):27. PubMed ID: 34011412
[TBL] [Abstract][Full Text] [Related]
27. TP53 status and impact on AML prognosis within the ELN 2022 risk classification.
Fleming S; Tsai XC; Morris R; Hou HA; Wei AH
Blood; 2023 Dec; 142(23):2029-2033. PubMed ID: 37647854
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcomes and characteristics of patients with
Zhang L; Chen K; Li Y; Chen Q; Shi W; Ji T; Tao H; He Z; Wang C; Yu L
Hematology; 2023 Dec; 28(1):2181773. PubMed ID: 36892252
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
30. MLL gene amplification in acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation.
Tang G; DiNardo C; Zhang L; Ravandi F; Khoury JD; Huh YO; Muzzafar T; Medeiros LJ; Wang SA; Bueso-Ramos CE
Hum Pathol; 2015 Jan; 46(1):65-73. PubMed ID: 25387813
[TBL] [Abstract][Full Text] [Related]
31. TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution.
Hou HA; Chou WC; Kuo YY; Liu CY; Lin LI; Tseng MH; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Li CC; Huang SY; Ko BS; Hsu SC; Chen CY; Lin CT; Wu SJ; Tsay W; Chen YC; Tien HF
Blood Cancer J; 2015 Jul; 5(7):e331. PubMed ID: 26230955
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of clinical features of patients with de novo primary acute myeloid leukemia and various chromosomal karyotypes].
Jiao Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Oct; 35(5):727-732. PubMed ID: 30298506
[TBL] [Abstract][Full Text] [Related]
33. Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogenetics.
Nazha A; Kantarjian HM; Bhatt VR; Nogueras-Gonzalez G; Cortes JE; Kadia T; Garcia-Manero G; Abruzzo L; Daver N; Pemmaraju N; Quintas-Cardama A; Ravandi F; Keating M; Borthakur G
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):163-71. PubMed ID: 24461514
[TBL] [Abstract][Full Text] [Related]
34. Unbalanced translocation der(5;17) resulting in a TP53 loss as recurrent aberration in myelodysplastic syndrome and acute myeloid leukemia with complex karyotype.
Warnstorf D; Bawadi R; Schienke A; Strasser R; Schmidt G; Illig T; Tauscher M; Thol F; Heuser M; Steinemann D; Davenport C; Schlegelberger B; Behrens YL; Göhring G
Genes Chromosomes Cancer; 2021 Jun; 60(6):452-457. PubMed ID: 33486841
[TBL] [Abstract][Full Text] [Related]
35. Concomitance of monosomal karyotype with at least 5 chromosomal abnormalities is associated with dismal treatment outcome of AML patients with complex karyotype - retrospective analysis of Polish Adult Leukemia Group (PALG).
Wierzbowska A; Wawrzyniak E; Siemieniuk-Rys M; Kotkowska A; Pluta A; Golos A; Robak T; Szarawarska M; Jaskowiec A; Duszenko E; Rybka J; Holojda J; Grosicki S; Pienkowska-Grela B; Woroniecka R; Ejduk A; Watek M; Wach M; Mucha B; Skonieczka K; Czyzewska M; Jachalska A; Klonowska A; Iliszko M; Knopinska-Posluszny W; Jarmuz-Szymczak M; Przybylowicz-Chalecka A; Gil L; Kopacz A; Holowiecki J; Haus O
Leuk Lymphoma; 2017 Apr; 58(4):889-897. PubMed ID: 27561449
[TBL] [Abstract][Full Text] [Related]
36. [Clinical and prognostic values of TP53 mutation in patients with acute myeloid leukemia].
Zhang Y; Hu XX; Gao L; Ni X; Chen J; Chen L; Zhang WP; Yang JM; Wang JM
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):932-938. PubMed ID: 31856443
[No Abstract] [Full Text] [Related]
37. Predictive value of TP53 fluorescence in situ hybridization in cytogenetic subgroups of acute myeloid leukemia.
Tavor S; Rothman R; Golan T; Voskoboinik N; Katz BZ; Sarid N; Shomrat R; Orr-Urtreger A; Naparstek E
Leuk Lymphoma; 2011 Apr; 52(4):642-7. PubMed ID: 21323513
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Poiré X; Labopin M; Maertens J; Yakoub-Agha I; Blaise D; Ifrah N; Socié G; Gedde-Dhal T; Schaap N; Cornelissen JJ; Vigouroux S; Sanz J; Michaux L; Esteve J; Mohty M; Nagler A
J Hematol Oncol; 2017 Jan; 10(1):20. PubMed ID: 28100265
[TBL] [Abstract][Full Text] [Related]
39. The prognostic impact of cigarette smoking on survival in acute myeloid leukemia with TP53 mutations and/or 17p deletions.
Bi X; French Z; Palmisiano N; Wen KY; Wilde L
Ann Hematol; 2022 Jun; 101(6):1251-1259. PubMed ID: 35288759
[TBL] [Abstract][Full Text] [Related]
40. iAMP21 in acute myeloid leukemia is associated with complex karyotype, TP53 mutation and dismal outcome.
Xie W; Xu J; Hu S; Li S; Wang W; Cameron Yin C; Toruner G; Tang Z; Medeiros LJ; Tang G
Mod Pathol; 2020 Jul; 33(7):1389-1397. PubMed ID: 32034282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
